Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALXN

Alexion Pharmaceuticals (ALXN) Stock Price, News & Analysis

Alexion Pharmaceuticals logo

About Alexion Pharmaceuticals Stock (NASDAQ:ALXN)

Advanced Chart

Key Stats

Today's Range
$182.50
$182.50
50-Day Range
$179.45
$186.61
52-Week Range
$99.91
$187.45
Volume
10 shs
Average Volume
3.31 million shs
Market Capitalization
$40.34 billion
P/E Ratio
59.64
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alexion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ALXN Stock News Headlines

Alexion Stock Price History
Alexion’s ravulizumab granted FDA orphan designation
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Monopar's Incredible Journey From $5 To $50 In Less Than 5 Months
AstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical Alliance
See More Headlines

ALXN Stock Analysis - Frequently Asked Questions

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) released its quarterly earnings data on Thursday, April, 29th. The biopharmaceutical company reported $3.52 earnings per share for the quarter, topping the consensus estimate of $3.16 by $0.36. Alexion Pharmaceuticals's quarterly revenue was up 13.3% on a year-over-year basis.

Alexion Pharmaceuticals subsidiaries include these companies: Portola Pharmaceuticals Inc., Achillion Pharmaceuticals, Syntimmune, Wilson Therapeutics, Synageva BioPharma Corp., Enobia Pharma Corp., Taligen Therapeutics Inc., and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alexion Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Bristol Myers Squibb (BMY), Tesla (TSLA), Netflix (NFLX), Gilead Sciences (GILD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
4/29/2021
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ALXN
Fax
N/A
Employees
3,837
Year Founded
1992

Profitability

Trailing P/E Ratio
59.64
Forward P/E Ratio
13.95
P/E Growth
0.93
Net Income
$603.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.07 billion
Cash Flow
$22.81 per share
Price / Cash Flow
8.00
Book Value
$53.24 per share
Price / Book
3.43

Miscellaneous

Free Float
N/A
Market Cap
$40.34 billion
Optionable
Optionable
Beta
1.25

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ALXN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners